title: [Evaluation of prescription practices for drugs charged in addition to DRG-based fees in Alsace].
abstract: Two studies led in parallel from May till June, 2009, were proposed in Alsace in order to           analyze the hospital practices of prescription relative to 6 drugs charged in addition to           the GHS: bevacizumab, gemcitabine, trastuzumab, etanercept, adalimumab and infliximab. The           first study, led within 9 hospitals, allowed the collection of 343 situations of           prescription. The second approach, based on the extraction of the PMSI data from the same           hospitals, allowed the exploitation of 771 situations of prescription. The data collected           on sites and from the PMSI respectively put in evidence 86.3% and 73.0% of prescriptions           corresponding to guidelines. No unacceptable situation was revealed. The differences           between approaches can be explained by the important proportion of unclassifiable           situations extracted from the PMSI. These approaches bring complementary lightings and           allow the OMEDIT of Alsace to take position in its missions of expertise and follow-up of           therapeutic innovations.
authors.affiliation: ARS d'Alsace, OMEDIT, Strasbourg, France.
authors.forename: Géraldine
authors.initials: G
authors.lastname: Kuss
authors.forename: Nicole
authors.initials: N
authors.lastname: Drogue
authors.forename: Bruno
authors.initials: B
authors.lastname: Michel
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003953:Diagnosis-Related Groups / Q000592:standards* / Q000706:statistics & numerical data; D011307:Drug Prescriptions / Q000592:standards* / Q000706:statistics & numerical data; D004358:Drug Therapy / Q000592:standards / Q000706:statistics & numerical data; D004363:Drug Utilization; D005252:Fees, Pharmaceutical; D005602:France / Q000453:epidemiology; D019983:Guideline Adherence / Q000592:standards* / Q000706:statistics & numerical data; D006801:Humans; D011364:Professional Practice
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents